Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Amphastar Pharmaceuticals Inc.
DescriptionLow molecular weight heparin
Molecular Target Factor Xa ; Thrombin (Factor IIa) (F2)
Mechanism of Action 
Therapeutic ModalityMacromolecule: Polysaccharide
Latest Stage of DevelopmentMarketed
Standard IndicationDeep vein thrombosis (DVT)
Indication DetailsTreat deep vein thrombosis (DVT)
Regulatory Designation
PartnerAllergan plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today